News & Updates

Opioid Policy Stakeholder Meetings - Oct. 27 & Nov. 14

The Division of Professions and Occupations (DPO) in the Department of Regulatory Agencies is hosting two more stakeholder meetings in Denver to discuss potential updates to the Policy for Prescribing and Dispensing Opioids (Policy).

The Colorado healthcare licensing boards are seeking public input so they can understand the needs of Coloradans and the impact of the current Policy on Colorado communities. Input received will inform the Boards’ decision making as they begin to revise the Policy, which serves the dual purpose of treating the individual patient and improving public health. 

DPO invites anyone to attend these meetings to offer feedback and ideas regarding the Policy. This forum follows four previous Community Meetings held in Pueblo, Greeley and Denver over the past year.

Meeting Information

Three Ways to Participate

  1. In Person: Civic Center Plaza, 1560 Broadway, Conference Room 1900, Denver, CO 80202.
  2. By Webinar: Register at the following links:
  3. By Written Comment: Provide written comments in advance or after the meeting to Holli Weaver at holli.weaver@state.co.us.

Meeting Format

Stakeholder input will be limited to discussion of the Policy for Prescribing and Dispensing Opioids. Oral comments will be taken from participants who are present in-person or participating via webinar. If you cannot make the meeting in person or wish to make written rather than oral comments, or if you have any questions or concerns about stakeholder input, please email holli.weaver@state.co.us.

 

Opioid Policy Stakeholder Recording

The Division of Professions and Occupations (DPO) in the Department of Regulatory Agencies hosted a stakeholder meeting on August 30, 2017 in Denver to discuss potential updates to the Policy for Prescribing and Dispensing Opioids (Policy).

The Colorado healthcare licensing boards continue to seek public input to understand the needs of Coloradans and the impact of the current Policy on Colorado communities. Input received at the August meeting will inform the Boards’ decision making as they begin to revise the Policy, which serves the dual purpose of treating the individual patient and improving public health. Attendees, both on-site and via webinar, shared their opinions on how revisions to the Policy will affect consumer outcomes, positively or negatively. Attendees' opinions and recommendations will help shape any final revisions of the Policy.

DPO welcomes feedback and ideas regarding the Policy. This forum followed three previous Community Meetings held in Pueblo, Greeley and Denver over the past year.

If you would like to provide comments on the Policy, please send them to holli.weaver@state.co.us. All comments will be incorporated into the official record when the Boards adopt any final revisions to the Policy. Staff will identify your comments as information received in anticipation of the development of a revised Policy.

An additional Stakeholder Meeting is planned for late September, but a date and time have not been set. Please watch this website to get the most updated information on this important topic. Questions can be sent to holli.weaver@state.co.us.

 

Policy Updates

Colorado Consortium Newsroom

Visit the Newsroom of the Colorado Consortium for Prescription Drug Abuse Prevention for recent media stories, reports, press releases, and other items related to the prescription drug abuse epidemic.

Delegated Access Training Video Coming Soon